ADC Therapeutics financial statements
ADC 테라퓨틱스NYSE:ADCT · New York Stock Exchange · Healthcare · sector #16$1.27+3.25%
2026-10-06 close · prelimADC Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $71M. 2024 operating profit was −$131M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy